Physician profile
Daniel M Burchfield
NPI 1366418741
$477.20
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $108 · 2021: $208.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $199.54 | 2019-2021 | |
| Abbott Laboratories | $109.35 | 2019-2021 | |
| Orthogenrx INC. | $47.60 | 2019 | |
| Electronic Waveform Lab, INC. | $32.39 | 2019-2020 | |
| Ethicon US, LLC | $25.71 | 2019 | |
| Orthofix Medical, INC. | $20.73 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $15.81 | 2021 | |
| Radius Health, INC. | $15.02 | 2021 | |
| Vericel Corporation | $11.05 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Burchfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.